loading

Anika Therapeutics Inc Azioni (ANIK) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
5.70%
40.52
42.97 41.47 44.30 37.92
Cost Of Revenue
4.49%
15.89
16.64 16.52 15.33 15.08
Gross Profit
6.46%
24.63
26.33 24.94 28.97 22.84
Operating Expenses
67.05%
29.69
90.11 32.62 32.60 35.40
Benefits Costs and Expenses
57.62%
44.99
106.17 48.50 47.37 49.94
Costs And Expenses
67.05%
29.69
90.11 32.62 32.60 35.40
Depreciation and Amortization
6.51%
1.734
1.628 1.596 1.605 1.605
Operating Income/Loss
92.06%
-5.063
-63.78 -7.674 -3.631 -12.55
Income/Loss From Continuing Operations Before Tax
92.93%
-4.471
-63.20 -7.039 -3.07 -12.01
Income Tax Expense/Benefit, Deferred
110.47%
0.193
-1.843 -1.207 -0.904 -2.373
Income Tax Expense/Benefit
121.08%
0.043
-0.204 -0.463 -0.329 -1.664
Income/Loss From Continuing Operations After Tax
92.83%
-4.514
-63.00 -6.576 -2.741 -10.35
Net Income/Loss
92.83%
-4.514
-63.00 -6.576 -2.741 -10.35
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
490.03K%
14.70
-0.003 14.63 14.69 14.65
Diluted Average Shares
490.03K%
14.70
-0.003 14.63 14.69 14.65
Basic Earnings Per Share
92.79%
-0.31
-4.30 -0.45 -0.19 -0.71
Diluted Earnings Per Share
92.79%
-0.31
-4.30 -0.45 -0.19 -0.71
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$11.63
price down icon 1.61%
$89.28
price down icon 2.89%
$83.45
price down icon 0.82%
drug_manufacturers_specialty_generic RDY
$15.37
price up icon 1.65%
$135.42
price up icon 0.34%
$12.52
price up icon 3.22%
Capitalizzazione:     |  Volume (24 ore):